Literature DB >> 12768411

Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis.

D Hot1, R Antoine, G Renauld-Mongénie, V Caro, B Hennuy, E Levillain, L Huot, G Wittmann, D Poncet, F Jacob-Dubuisson, C Guyard, F Rimlinger, L Aujame, E Godfroid, N Guiso, M-J Quentin-Millet, Y Lemoine, C Locht.   

Abstract

The production of most factors involved in Bordetella pertussis virulence is controlled by a two-component regulatory system termed BvgA/S. In the Bvg+ phase virulence-activated genes (vags) are expressed, and virulence-repressed genes (vrgs) are down-regulated. The expression of these genes can also be modulated by MgSO(4) or nicotinic acid. In this study we used microarrays to analyse the influence of BvgA/S or modulation on the expression of nearly 200 selected genes. With the exception of one vrg, all previously known vags and vrgs were correctly assigned as such, and the microarray analyses identified several new vags and vrgs, including genes coding for putative autotransporters, two-component systems, extracellular sigma factors, the adenylate cyclase accessory genes cyaBDE, and two genes coding for components of a type III secretion system. For most of the new vrgs and vags the results of the microarray analyses were confirmed by RT-PCR analysis and/or lacZfusions. The degree of regulation and modulation varied between genes, and showed a continuum from strongly BvgA/S-activated genes to strongly BvgA/S-repressed genes. The microarray analyses also led to the identification of a subset of vags and vrgs that are differentially regulated and modulated by MgSO(4) or nicotinic acid, indicating that these genes may be targets for multiple regulatory circuits. For example, the expression of bilA, a gene predicted to encode an intimin-like protein, was found to be activated by BvgA/S and up-modulated by nicotinic acid. Furthermore, surprisingly, in the strain analysed here, which produces only type 2 fimbriae, the fim3 gene was identified as a vrg, while fim2 was confirmed to be a vag.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768411     DOI: 10.1007/s00438-003-0851-1

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  26 in total

Review 1.  Bordetella pertussis, molecular pathogenesis under multiple aspects.

Authors:  C Locht; R Antoine; F Jacob-Dubuisson
Journal:  Curr Opin Microbiol       Date:  2001-02       Impact factor: 7.934

2.  Characterization of the type III secretion locus of Bordetella pertussis.

Authors:  A Fauconnier; A Veithen; P Gueirard; R Antoine; L Wacheul; C Locht; A Bollen; E Godfroid
Journal:  Int J Med Microbiol       Date:  2001-03       Impact factor: 3.473

3.  New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis.

Authors:  R Antoine; S Alonso; D Raze; L Coutte; S Lesjean; E Willery; C Locht; F Jacob-Dubuisson
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

4.  Characterization of a Bordetella pertussis fimbrial gene cluster which is located directly downstream of the filamentous haemagglutinin gene.

Authors:  R J Willems; H G van der Heide; F R Mooi
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

5.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

6.  Environmental regulation of expression of virulence determinants in Bordetella pertussis.

Authors:  A R Melton; A A Weiss
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

Review 7.  Molecular aspects of Bordetella pertussis pathogenesis.

Authors:  C Locht
Journal:  Int Microbiol       Date:  1999-09       Impact factor: 2.479

8.  Identification and characterization of BipA, a Bordetella Bvg-intermediate phase protein.

Authors:  K E Stockbauer; B Fuchslocher; J F Miller; P A Cotter
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

9.  Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica.

Authors:  F D Menozzi; C Gantiez; C Locht
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction.

Authors:  B J Akerley; P A Cotter; J F Miller
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  26 in total

1.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Assembly of fimbrial structures in Pseudomonas aeruginosa: functionality and specificity of chaperone-usher machineries.

Authors:  Ségolène Ruer; Silke Stender; Alain Filloux; Sophie de Bentzmann
Journal:  J Bacteriol       Date:  2007-02-09       Impact factor: 3.490

3.  Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses.

Authors:  Neil K Fennelly; Federico Sisti; Sarah C Higgins; Pádraig J Ross; Han van der Heide; Frits R Mooi; Aoife Boyd; Kingston H G Mills
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

Review 4.  Bioinformatics annotation of the hypothetical proteins found by omics techniques can help to disclose additional virulence factors.

Authors:  Sergio Hernández; Antonio Gómez; Juan Cedano; Enrique Querol
Journal:  Curr Microbiol       Date:  2009-07-28       Impact factor: 2.188

5.  Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality.

Authors:  M E Gaillard; D Bottero; C E Castuma; L A Basile; D Hozbor
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

6.  A Novel Bvg-Repressed Promoter Causes vrg-Like Transcription of fim3 but Does Not Result in the Production of Serotype 3 Fimbriae in Bvg- Mode Bordetella pertussis.

Authors:  Qing Chen; Gloria Lee; Candice Craig; Victoria Ng; Paul E Carlson; Deborah M Hinton; Scott Stibitz
Journal:  J Bacteriol       Date:  2018-09-24       Impact factor: 3.490

Review 7.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

8.  Activation of Bvg-Repressed Genes in Bordetella pertussis by RisA Requires Cross Talk from Noncooperonic Histidine Kinase RisK.

Authors:  Qing Chen; Victoria Ng; Jason M Warfel; Tod J Merkel; Scott Stibitz
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

9.  Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.

Authors:  Carolina Salcedo-Rivillas; Anne-Sophie Debrie; Eliane Namie Miyaji; Jorge M C Ferreira; Isaías Raw; Camille Locht; Paulo L Ho; Nathalie Mielcarek; Maria Leonor S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

10.  In vivo phosphorylation dynamics of the Bordetella pertussis virulence-controlling response regulator BvgA.

Authors:  Alice Boulanger; Qing Chen; Deborah M Hinton; Scott Stibitz
Journal:  Mol Microbiol       Date:  2013-03-14       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.